Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Latin America Investor Daily.
Press releases published on March 31, 2025
American Assets Trust, Inc. Announces First Quarter 2025 Earnings Release Date and Conference Call Information
GlobeNewswire
·
March 31, 2025
SAN DIEGO, March 31, 2025 (GLOBE NEWSWIRE) -- American Assets Trust, Inc. (NYSE:AAT) (the “Company”) will announce its first quarter 2025 earnings in a press release to be issued after the market closes on Tuesday, April 29, 2025. Senior management will …
Xtreme One Entertainment Announces Full Year 2024 Financial Results
GlobeNewswire
·
March 31, 2025
DETROIT, March 31, 2025 (GLOBE NEWSWIRE) -- Xtreme One Entertainment, Inc. (OTCPink: XONI) today announced its financial results for the full year ending December 31, 2024, details of which have been filed within the Company’s annual disclosure statement …
Norwood Financial Corp Announces Cash Dividend
GlobeNewswire
·
March 31, 2025
HONESDALE, Pa., March 31, 2025 (GLOBE NEWSWIRE) -- James O. Donnelly, President and Chief Executive Officer of Norwood Financial Corp (NASDAQ Global Market - NWFL) and its subsidiary Wayne Bank, announced that the Board of Directors has declared a $0.31 …
Binah Capital Group Reports Fourth Quarter and Full Year 2024 Results
GlobeNewswire
·
March 31, 2025
- Grew Total Revenue 8% Year-over-Year to $45 Million in the Fourth Quarter 2024 - - Assets Under Management (“AuM”) Increased 13% Year-over-Year to $27 Billion - - GAAP Net Loss of $1.1 Million in the Fourth Quarter - - Grew Adjusted EBITDA* 43% Year-Over …
Duos Technologies Group Reports 4th Quarter and FY 2024 Results
GlobeNewswire
·
March 31, 2025
Issues guidance following a transformative year with the Company adding two new business lines, significantly strengthening the Balance Sheet and demonstrating enhanced operational capabilities for additional services and consulting related to the fast …
AleAnna, Inc. Reports Fiscal Year 2024 Results
GlobeNewswire
·
March 31, 2025
A Series of Milestones, Including Public Listing, Were Achieved in 2024; Longanesi First Gas Production Has Been Achieved Fiscal Year 2024 and Recent Company Highlights: Gas production at Longanesi has commenced as of March 13, 2025 Between March 2024 and …
Nova LifeStyle Announces Fiscal 2024 Financial Results
GlobeNewswire
·
March 31, 2025
LOS ANGELES, March 31, 2025 (GLOBE NEWSWIRE) -- Nova LifeStyle, Inc. (NASDAQ: NVFY) (“Nova LifeStyle” or the “Company”) today announced financial results for the fiscal year ended December 31, 2024. Tawny Lam, Chairperson and Chief Executive Officer of …
Zevra Therapeutics Files Preliminary Proxy
GlobeNewswire
·
March 31, 2025
Confirms Receipt of Two Director Nominees from Daniel J. Mangless Stockholders Are Not Required to Take Action at This Time CELEBRATION, Fla., March 31, 2025 (GLOBE NEWSWIRE) -- Zevra Therapeutics, Inc. (Nasdaq:GS ZVRA) (“Zevra,” or the “Company”), a …
Ellomay Capital Reports Publication of Financial Statements of Dorad Energy Ltd. for the Year Ended December 31, 2024
GlobeNewswire
·
March 31, 2025
TEL-AVIV, Israel, March 31, 2025 (GLOBE NEWSWIRE) -- Ellomay Capital Ltd. (NYSE American; TASE: ELLO) (“Ellomay” or the “Company”), a renewable energy and power generator and developer of renewable energy and power projects in Europe, Israel and USA, today …
Calidi Biotherapeutics Reports Fourth Quarter and Full-Year 2024 Financial Results and Recent Operational Highlights
GlobeNewswire
·
March 31, 2025
Announced demonstrated ability to deliver transient gene therapy (payload) to tumors using systemic antitumor virotherapy platform Filed IND in March 2025 for CLD-201 company sponsored Phase 1 trial to treat multiple solid tumors Commencement of …
Aardvark Therapeutics Reports Full Year 2024 Financial Results and Provides Business Highlights
GlobeNewswire
·
March 31, 2025
Lead candidate ARD-101 demonstrated clinical activity and was generally well tolerated in a two-part Phase 2 trial in Prader-Willi Syndrome (PWS), with meaningful reductions in hyperphagia (up to a 16-point HQ-CT reduction, with an average reduction of …
Biomea Fusion Reports Fourth Quarter and Full Year 2024 Financial Results and Corporate Highlights
GlobeNewswire
·
March 31, 2025
Mick Hitchcock, Ph.D., appointed Interim Chief Executive Officer Biomea preparing icovamenib for late-stage clinical development Multiple milestones anticipated in 2025 including: FDA meeting anticipated in first half 2025 to discuss icovamenib late-stage …
Archimedes Tech SPAC Partners II Co. Announces the Separate Trading of its Ordinary Shares and Warrants Commencing April 3, 2025
GlobeNewswire
·
March 31, 2025
CLAYMONT, Del., March 31, 2025 (GLOBE NEWSWIRE) -- Archimedes Tech SPAC Partners II Co. (Nasdaq: ATIIU) (the “Company”) today announced that, commencing April 3, 2025, holders of the units sold in the Company’s initial public offering may elect to …
FRP Holdings Announces Investor Day, Conference Participation and its New Investor Website and Presentation
GlobeNewswire
·
March 31, 2025
JACKSONVILLE, Fla., March 31, 2025 (GLOBE NEWSWIRE) -- FRP Holdings, Inc. (NASDAQ: FRPH) announced today several updates regarding its investor engagement initiatives. 2025 Investor Day – Save the Date The Company will host an Investor Day on May 22nd, …
Surrozen Provides Fourth Quarter and Full Year 2024 Financial Results and Business Updates
GlobeNewswire
·
March 31, 2025
SOUTH SAN FRANCISCO, Calif., March 31, 2025 (GLOBE NEWSWIRE) -- Surrozen, Inc. (“Surrozen” or the “Company”) (Nasdaq: SRZN), a company pioneering targeted therapeutics that selectively activate the Wnt pathway for tissue repair and regeneration, with a …
Reviva Reports Full Year 2024 Financial Results and Recent Business Highlights
GlobeNewswire
·
March 31, 2025
– Favorable long-term safety and robust broad-spectrum efficacy sustained over 1-year for once daily brilaroxazine in open-label extension (OLE) trial – – Registrational Phase 3 RECOVER-2 trial initiation for brilaroxazine expected mid-2025 – – Full data …
Rekor Systems Reports Strong 2024 Financial Results Highlighted by Record Revenue and Significant Operational Improvements
GlobeNewswire
·
March 31, 2025
Record Gross Revenue: Achieved record annual gross revenue of $46.0 million, representing a 32% increase from $34.9 million in 2023. Fourth Quarter Results: Gross revenue reached an all-time quarterly high of $13.3 million in Q4 2024, marking a 20% …
Fortress Biotech Reports 2024 Financial Results and Recent Corporate Highlights
GlobeNewswire
·
March 31, 2025
Emrosi™ approved by FDA for the treatment of inflammatory lesions of rosacea in adults, with commercial launch underway; initial distribution ongoing and first prescriptions filled Fortress subsidiary Checkpoint Therapeutics to be acquired by Sun Pharma; …
Allarity Therapeutics Reports Full Year 2024 Financial Results and Provides a Business Update
GlobeNewswire
·
March 31, 2025
Cash and cash receivable balance of $20.9 million as of December 31, 2024, expected to fund operations, including clinical activities into 2027 Strengthened cash position expected to support the Company through first substantive data readout in …
Progress Announces First Quarter 2025 Financial Results
GlobeNewswire
·
March 31, 2025
Annualized Recurring Revenue ("ARR") of $836 million Grew 48% year-over-year Revenue of $238 million Grew 29% year-over-year ShareFile Integration Underway BURLINGTON, Mass., March 31, 2025 (GLOBE NEWSWIRE) -- Progress (Nasdaq: PRGS), the trusted provider …